RMD

#442
ResMed Inc. Common Stock
200.1 9 USD
-2.41%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
198.82
205.09
Intervallo Annuale
2.07
277.67
Variazione giornaliera
-2.41%
Variazione Mensile
-5.78%
Variazione di 6 mesi
-16.59%
Variazione Annuale
-22.71%
Chiusura Precedente
205.1 4
Open
203.8 1
Minimo
198.8 2
High
205.0 9
Volume
382
Apri il grafico completo Full chart

Financials

Panoramica Estratto Conto Statistiche Dividendi
Trimestrale Annuale
  • Market Capitalization 29.04 B
  • Employee 11 K
  • Founded N/A
  • CEO Michael J. Farrell
  • Website www.resmed.com
  • Headquarter Delaware, United States
  • FIGI BBG000L4M7F1
  • Industry Strumenti e Forniture Mediche
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
27.13
Rapporto prezzo/fatturato
7.39
Dividendi per azione
2.12
Rendimento da dividendi %
0.82

ResMed Inc. Common Stock

ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease, and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19. Resmed also provides software to out-of-hospital care agencies to streamline transitions of care into and between these care settings for seniors and their care providers. Resmed employs more than 8,000 people worldwide as of June 2022. The company operates in more than 140 countries worldwide, and has manufacturing facilities in Australia, Singapore, France, and the United States. Revenue was US$4.7 billion in fiscal year 2024.

Notizie